| 2026 | Prognostic Impact of TP53 and RB1 Alterations in Metastatic Castration-Resistant Prostate Cancer Treated with Docetaxel | CANCER INVESTIGATION |
| 2026 | Revo-i VS Da Vinci in Robotic Partial Nephrectomy: First Human Comparison | JOURNAL OF ENDOUROLOGY |
| 2026 | Impact of carcinoma in situ of bladder at transurethral resection and radical cystectomy on survival: Retrospective multicenter study
| INVESTIGATIVE AND CLINICAL UROLOGY |
| 2025 | Effectiveness and Safety of Mirabek Sustained-release 50 mg Tablets in Korean Patients with Overactive Bladder: A Multicenter Observational Study at Tertiary General Hospitals
| EUROPEAN UROLOGY OPEN SCIENCE |
| 2025 | Prognosis of Prostate Cancer With Mucinous Components: A Propensity Score-Matched Study
| Journal of Urologic Oncology |
| 2025 | Impact of β3-adrenergic receptor agonist on kidney cancer risk in patients with overactive bladder | BJU INTERNATIONAL |
| 2025 | BAP1 as a predictive biomarker of therapeutic response to oncolytic vaccinia virus for metastatic renal cell carcinoma therapy | CANCER IMMUNOLOGY IMMUNOTHERAPY |
| 2025 | Letter to the editor: Multi-center, prospective, non-interventional, observational study on the efficacy and safety of Mirabek® in adult patients with overactive bladder-The author's reply
| INVESTIGATIVE AND CLINICAL UROLOGY |
| 2025 | Usefulness of free PSA ratio to enhance detection of clinically significant prostate cancer in patients with PI-RADS<3 and PSA≤10
| PROSTATE INTERNATIONAL |
| 2025 | Impact of β3-adrenergic receptor agonist on tumor progression and metastasis in renal cell carcinoma models
| CANCER CELL INTERNATIONAL |
| 2025 | Multi-center, prospective, non-interventional, observational study on the efficacy and safety of Mirabek® in adult patients with overactive bladder
| INVESTIGATIVE AND CLINICAL UROLOGY |
| 2024 | Incidence and Pattern of Recurrence after Surgical Resection in Organ-Confined Renal Cell Carcinoma | YONSEI MEDICAL JOURNAL |
| 2024 | Single-port robot-assisted pyeloplasty using the da Vinci SP system versus multi-port pyeloplasty: Comparison of outcomes and costs | Asian Journal of Surgery |
| 2024 | Lymphatic embolization for early post-operative lymphatic leakage after radical cystectomy for bladder cancer | PLOS ONE |
| 2024 | Short-term outcomes of intravesical gemcitabine for non-muscle-invasive bladder cancer after recent approval for use in Korea | INVESTIGATIVE AND CLINICAL UROLOGY |
| 2024 | The Role of Local Prostate and Metastasis-Directed Radiotherapy in the Treatment of Oligometastatic Prostate Cancer | CANCERS |
| 2024 | The role of cytoreductive nephrectomy in metastatic renal cell carcinoma in immune-oncology era (SEVURO-CN): study protocol for a multi-center, prospective, randomized trial | TRIALS |
| 2024 | ctDNA predicts clinical T1a to pathological T3a upstaging after partial nephrectomy | CANCER SCIENCE |
| 2024 | Clinical Validation of the Proenkephalin (PENK) Methylation Urine Test for Monitoring Recurrence of Non-muscle-invasive Bladder Cancer | EUROPEAN UROLOGY OPEN SCIENCE |
| 2024 | Risks of Dementia After Treatment with an Anticholinergic, Beta-3 Agonist, or Combination of Both for an Overactive Bladder: A Korean National Cohort Study | EUROPEAN UROLOGY FOCUS |
| 2024 | Radical prostatectomy versus radiotherapy as local therapy for primary tumors in patients with oligometastatic prostate cancer | FRONTIERS IN ONCOLOGY |
| 2024 | Effect of cytoreductive nephrectomy on the efficacy of immunotherapy in metastatic renal cell carcinoma by decreasing IL-6 to modulate tumor-associated macrophage and myeloid-derived suppressor cell. | Journal of Clinical Oncology |
| 2024 | Role of Maximal Transurethral Resection Preceding Partial Cystectomy for Muscle-Invasive Bladder Cancer | ANNALS OF SURGICAL ONCOLOGY |
| 2024 | The role of cytoreductive nephrectomy in metastatic renal cell carcinoma in immune-oncology era (SEVURO-CN): A study protocol for a multi-center, prospective, randomized trial | Journal of Clinical Oncology |
| 2024 | PD-1 inhibitor plus oncolytic vaccinia virus is a safe and effective treatment option for metastatic renal cell carcinoma | CANCER CELL INTERNATIONAL |
| 2023 | Prediction of Stent Failure for Malignant Ureteral Obstruction in Non-Urological Cancer | YONSEI MEDICAL JOURNAL |
| 2023 | TNM-Based Head-to-Head Comparison of Urachal Carcinoma and Urothelial Bladder Cancer: Stage-Matched Analysis of a Large Multicenter National Cohort | CANCER RESEARCH AND TREATMENT |
| 2023 | Phosphodiesterase-5 Inhibitor Use in Robot Assisted Radical Prostatectomy Patients Is Associated with Reduced Risk of Death: A Propensity Score Matched Analysis of 1,058 Patients | The World Journal of Men's Health |
| 2023 | Outcomes of single-port robotic ureteral reconstruction using the da Vinci SP® system | INVESTIGATIVE AND CLINICAL UROLOGY |
| 2023 | The Prognostic Impact of Angiolymphatic Invasion in Bladder Urothelial Carcinoma Patients Undergoing Radical Cystectomy
| Korean Journal of Urological Oncology |
| 2023 | Bladder Preservation With Transurethral Tumor Resection and Intravesical BCG Instillation in Superficial Muscle-Invasive Bladder Cancer: A 10-Year Follow-up | Journal of Urologic Oncology |
| 2023 | Association between β3-adrenergic receptor agonist use and risk of kidney cancer among patients with overactive bladder. | Journal of Clinical Oncology |
| 2022 | Noninvasive studies may have potential to replace cystoscopy in non-muscle invasive bladder cancer follow-up | Scientific Reports |
| 2022 | Characteristics of BRCA2 Mutated Prostate Cancer at Presentation | International Journal of Molecular Sciences |
| 2022 | Clinical Implications for da Vinci SP Partial Nephrectomy in High-Complexity Tumors: Propensity Score-Matching Analysis | Journal of Endourology |
| 2022 | Nephron-Sparing Approaches in Upper Tract Urothelial Carcinoma: Current and Future Strategies | Biomedicines |
| 2022 | External validation of karyotype nomogram to predict karyotype abnormalities in oligospermic men | ANDROLOGIA |
| 2022 | Evaluation of the Surgical Margin Threshold for Avoiding Recurrence after Partial Nephrectomy in Patients with Renal Cell Carcinoma | Yonsei Medical Journal |
| 2022 | Gene Expression Analysis of Aggressive Adult Xp11.2 Translocation Renal Cell Carcinoma at Clinical Stage T1N0M0 to Identify Potential Prognostic and Therapeutic Biomarkers | Biomedicines |
| 2022 | Systemic Injection of Oncolytic Vaccinia Virus Suppresses Primary Tumor Growth and Lung Metastasis in Metastatic Renal Cell Carcinoma by Remodeling Tumor Microenvironment | Biomedicines |
| 2021 | Prostate epithelial genes define therapy-relevant prostate cancer molecular subtype | PROSTATE CANCER AND PROSTATIC DISEASES |
| 2021 | Comparison of intraoperative and short-term postoperative outcomes between robot-assisted laparoscopic multi-port pyeloplasty using the da Vinci Si system and single-port pyeloplasty using the da Vinci SP system in children | Investigative and Clinical Urology |
| 2021 | Prognostic value of prostate volume in non-muscle invasive bladder cancer | Scientific Reports |
| 2021 | Effect of Dexmedetomidine on Biochemical Recurrence in Patients after Robot-Assisted Laparoscopic Radical Prostatectomy: A Retrospective Study | Journal of Personalized Medicine |
| 2021 | Revisiting extraprostatic extension based on invasion depth and number for new algorithm for substaging of pT3a prostate cancer | Scientific Reports |
| 2021 | The DEAD/DEAH Box Helicase, DDX11, Is Essential for the Survival of Advanced Clear Cell Renal Cell Carcinoma and Is a Determinant of PARP Inhibitor Sensitivity | Cancers |
| 2021 | The Prognosis and Oncological Predictor of Urachal Carcinoma of the Bladder: A Large Scale Multicenter Cohort Study Analyzed 203 Patients With Long Term Follow-Up | FRONTIERS IN ONCOLOGY |
| 2021 | Clinical Outcomes After Urinary Diversion for Malignant Ureteral Obstruction Secondary to Non-urologic Cancer: An Analysis of 778 Cases | ANNALS OF SURGICAL ONCOLOGY |
| 2021 | Development of a highly pulmonary metastatic orthotopic renal cell carcinoma murine model | BIOLOGY OPEN |
| 2021 | Association between visceral adiposity and DDX11 as a predictor of aggressiveness of small clear-cell renal-cell carcinoma: a prospective clinical trial | CANCER & METABOLISM |
http://orcid.org/0000-0002-9082-0381
(56646805300)
